07/02/2019 / By Evangelyn Rodriguez
In this study, researchers from The Chinese University of Hong Kong evaluated the anti-tumor, bone-protective, and immunomodulatory effects of an herbal formula consisting of four herbs used in traditional Chinese medicine (TCM) against metastatic breast cancer. The results of their study were published in the journal Chinese Medicine.
Based on these findings, the researchers concluded that their Chinese herbal formula possesses antitumor, anti-metastatic, and bone-protective activities against metastatic breast cancer. They hope that their preclinical data would lead to the use of TCM as adjuvant therapy to chemotherapeutic agents.
Read the full study at this link.
Journal Reference:
Yue GGL, Lee JKM, Chan BCL, Kwok HF, Hoi SWH, Sze DMY, Fung KP, Leung PC, Lau CBS. AN INNOVATIVE ANTI-CANCER CHINESE HERBAL FORMULA EXHIBITED MULTI-TARGETED EFFICACIES IN METASTATIC BREAST CANCER MOUSE MODEL. Chinese Medicine. 22 December 2018;13(1):64. DOI: 10.1186/s13020-018-0222-9
Tagged Under: Acanthopanax senticosus, adjuvant therapy, alternative medicine, andrographis paniculata, anti-inflammatory, anticancer, antioxidant, antitumor, bone-protective, breast cancer, Camellia sinensis, cancer cures, cancer treatment, chemotherapeutic agents, disease treatments, doxorubicin, Hedyotis diffusa, herbal medicine, Herbs, immune system, immunomodulatory, longevity, natural cures, natural medicine, prevention, remedies, research, TCM, traditional Chinese medicine, women's health
PlantMedicine.News is a fact-based public education website published by Plant Medicine News Features, LLC.
All content copyright © 2018 by Plant Medicine News Features, LLC.
Contact Us with Tips or Corrections
All trademarks, registered trademarks and servicemarks mentioned on this site are the property of their respective owners.